Trials / Terminated
TerminatedNCT01264133
A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B
An Open Study to Evaluate the Efficacy, Safety and Sustained Effect of Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With Chronic Hepatitis B
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Bukwang Pharmaceutical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An open study to Evaluate the Efficacy, Safety and Sustained effect of Clevudine monotherapy or Adefovir and Clevudine combination in proportion to Roadmap concept in Patients with chronic hepatitis B.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clevudine, Adefovir | Clevudine 30mg qd or Clevudine 30mg + Adefovir 10mg qd |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2013-06-01
- Completion
- 2014-12-01
- First posted
- 2010-12-21
- Last updated
- 2014-12-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01264133. Inclusion in this directory is not an endorsement.